Kushibiki T - Search Results

1

HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in mice.

Obata Y, Nishino T, Kushibiki T, Tomoshige R, Xia Z, Miyazaki M, Abe K, Koji T, Tabata Y, Kohno S. Obata Y, et al. Among authors: kushibiki t. Acta Biomater. 2012 Jul;8(7):2688-96. doi: 10.1016/j.actbio.2012.03.050. Epub 2012 Apr 6. Acta Biomater. 2012. PMID: 22487929

2

Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.

Kushibiki T, Matsumoto K, Nakamura T, Tabata Y. Kushibiki T, et al. Pharm Res. 2004 Jul;21(7):1109-18. doi: 10.1023/b:pham.0000032996.95518.dc. Pharm Res. 2004. PMID: 15290849

3

Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis.

Kushibiki T, Nagata-Nakajima N, Sugai M, Shimizu A, Tabata Y. Kushibiki T, et al. J Control Release. 2005 Jul 20;105(3):318-31. doi: 10.1016/j.jconrel.2005.02.030. J Control Release. 2005. PMID: 15936840

4

Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds.

Kushibiki T, Tomoshige R, Iwanaga K, Kakemi M, Tabata Y. Kushibiki T, et al. J Control Release. 2006 May 15;112(2):249-56. doi: 10.1016/j.jconrel.2006.02.003. Epub 2006 Mar 20. J Control Release. 2006. PMID: 16545479

5

Suppression of tumor metastasis by NK4 plasmid DNA released from cationized gelatin.

Kushibiki T, Matsumoto K, Nakamura T, Tabata Y. Kushibiki T, et al. Gene Ther. 2004 Aug;11(15):1205-14. doi: 10.1038/sj.gt.3302285. Gene Ther. 2004. PMID: 15103321

6

In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents.

Kushibiki T, Tomoshige R, Fukunaka Y, Kakemi M, Tabata Y. Kushibiki T, et al. J Control Release. 2003 Jun 24;90(2):207-16. doi: 10.1016/s0168-3659(03)00197-4. J Control Release. 2003. PMID: 12810303

7

Targeting of plasmid DNA to renal interstitial fibroblasts by cationized gelatin.

Kushibiki T, Nagata-Nakajima N, Sugai M, Shimizu A, Tabata Y. Kushibiki T, et al. Biol Pharm Bull. 2005 Oct;28(10):2007-10. doi: 10.1248/bpb.28.2007. Biol Pharm Bull. 2005. PMID: 16204967 Free article.

8

Preparation of poly(ethylene glycol)-introduced cationized gelatin as a non-viral gene carrier.

Kushibiki T, Tabata Y. Kushibiki T, et al. J Biomater Sci Polym Ed. 2005;16(11):1447-61. doi: 10.1163/156856205774472326. J Biomater Sci Polym Ed. 2005. PMID: 16370244

9

Enhanced anti-fibrotic activity of plasmid DNA expressing small interference RNA for TGF-beta type II receptor for a mouse model of obstructive nephropathy by cationized gelatin prepared from different amine compounds.

Kushibiki T, Nagata-Nakajima N, Sugai M, Shimizu A, Tabata Y. Kushibiki T, et al. J Control Release. 2006 Feb 21;110(3):610-7. doi: 10.1016/j.jconrel.2005.11.007. Epub 2005 Dec 27. J Control Release. 2006. PMID: 16378654

10

In vitro transfection of plasmid DNA by cationized gelatin prepared from different amine compounds.

Kushibiki T, Tomoshige R, Iwanaga K, Kakemi M, Tabata Y. Kushibiki T, et al. J Biomater Sci Polym Ed. 2006;17(6):645-58. doi: 10.1163/156856206777346278. J Biomater Sci Polym Ed. 2006. PMID: 16892726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters